Registered Number 12849897

PHARMA BUSINESS REVIEW LIMITED

Micro-entity Accounts

30 September 2024

PHARMA BUSINESS REVIEW LIMITED Registered Number 12849897

Micro-entity Balance Sheet as at 30 September 2024

Notes 2024 2023
£ £
Called up share capital not paid
-
-
Fixed Assets
93,149
-
Current Assets
155,553
19,435
Prepayments and accrued income
-
-
Creditors: amounts falling due within one year
0
(150)
Net current assets (liabilities)
155,553
19,285
Total assets less current liabilities
248,702
19,285
Creditors: amounts falling due after more than one year
(446,465)
(19,284)
Provisions for liabilities
0
0
Accruals and deferred income
0
0
Total net assets (liabilities)
(197,763)
1
Capital and reserves
(197,763)
1
  • For the year ending 30 September 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.
  • The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
  • The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
  • The accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

Approved by the Board on 4 March 2025

And signed on their behalf by:
ALARAN, Ayodeji Sunday, Director

PHARMA BUSINESS REVIEW LIMITED Registered Number 12849897

Notes to the Micro-entity Accounts for the period ended 30 September 2024

1Employees
2024 2023
Average number of employees during the period 2 0